arrow
S

Shira Zelber-Sagi

University of Haifa
H指数:56
被引数:2.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hepatology: Emerging Paradigms in MASLD, Viral Hepatitis, Cholestatic Liver Disease, Portal Hypertension and Hepatocellular Carcinoma

肝病学:MASLD、病毒性肝炎、胆汁淤积性肝病、门静脉高压和肝细胞癌的新兴范式

2026-08-300
PRE
Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study

代谢功能障碍相关的脂肪性肝病和代谢功能障碍相关的脂肪性肝炎的最佳购买: 全球Delphi研究

2025-12-130
PRE
Two-Decade Trends in MASLD and Its Complications in the Middle East and North Africa (2010–2021)

中东和北非地区MASLD及其并发症的二十年趋势(2010–2021)

2025-09-080
PRE
Erratum to American Society for Gastrointestinal Endoscopy–European Society of Gastrointestinal Endoscopy guideline on primary endoscopic bariatric and metabolic therapies for adults with obesity, Gastrointestinal Endoscopy Volume 99, Issue 6, June 2024, Pages 867-885.e64

成人肥胖患者初次内镜减重与代谢治疗美国胃肠内镜学会–欧洲胃肠内镜学会指南勘误,胃肠内镜 Volume 99, Issue 6, 2024年6月, Pages 867-885.e64

2025-07-290
PRE
Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis

代谢功能障碍相关脂肪性肝病和脂肪性肝炎的全球共识建议

2025-04-110
OAAI